Krystal Biotech Inc.

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

122.44%

Market Cap

-

P/E Ratio

36.05

Dividend Yield

0.00 %

Earnings per Share

6.06 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE293.4 G0 Units
PRICE DETERMINATION TIME07/24/2026 / 09:56:40 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW296.7285.1
PREV. DAY'S PRICE287.5 (07/23)
CHANGE DAY BEFORE
+5.90
2.05 %
52 WEEK HIGH / LOW334.1 (06/30)115.55 (08/07)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
0.362.776.066.508.72
DIVIDENDS PER SHARE
0.000.000.000.000.00
DIVIDEND YIELD IN %
0.00 %0.00 %0.00 %--
DIVIDEND GROWTH IN %
-----
PRICE - EARNINGS RATIO
314.9552.2536.0544.3233.01
PRICE - BOOK RATIO
4.504.775.90--
PRICE - SALES RATIO
67.9116.0418.98--
PRICE - CASH FLOW RATIO
-37.7536.76--
Further Key Figures

Master Data

WKN
A2JH2F
ISIN
US5011471027
SYMBOL
4KB
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
KRYSTAL BIOTECH DL-,00001
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
-
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
-
MARKET CAPITALISATION
-

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-3.33 %
-3.52 %
26.37 %
21.46 %
122.44 %
166.20 %
458.25 %
32.49 %
HIGH310.80334.10334.10334.10334.10334.10334.10334.10
LOW285.00285.00218.10209.70115.5587.0033.20204.10

Dividende

pro Aktie
KRYSTAL BIOTECH DL-,00001 does not deliver dividend information

Company profile

Krystal Biotech, Inc. operates as a biotechnology company, which engages in discovery, development, manufacturing, and commercialization of pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.